Join the Saxenda group to help and get support from people like you.
Saxenda News (Page 4)
FDA Approves Saxenda (liraglutide) for the Treatment of Obesity in Adolescents Aged 12-17
PLAINSBORO, N.J., Dec. 4, 2020 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved an updated label for Saxenda® (liraglutide) injection 3 mg for use...
Further information
Related condition support groups
Weight Loss (Obesity / Overweight)